{"data":{"id":786,"lang":"en","title":"Mirror-Image Amino Acid Starves Cancer Cells While Leaving Healthy Cells Untouched, Study Finds","summary":"D-cysteine, a mirror-image amino acid, selectively starves cancer cells by blocking a key mitochondrial enzyme while leaving healthy cells unharmed.","category":"science","category_label":"Science","published_at":"2026-03-14T07:02:07Z","updated_at":"2026-03-14T07:02:07Z","url":"https://techtools.cz/tools/news/article/786-mirror-image-amino-acid-starves-cancer-cells-while-leaving-healthy-cells","api_url":"https://techtools.cz/news-api/v1/articles/786?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/786.md?lang=en","image_url":"https://www.unige.ch/medias/application/files/8917/5515/3989/Martinou_CancerCell_Web.jpg","word_count":136,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/03/260311213453.htm","domain":"sciencedaily.com"},{"url":"https://www.miragenews.com/a-mirror-amino-acid-against-certain-tumors-1515000/","domain":"miragenews.com"}],"translation":{"lang":"cs","id":807,"title":"Zrcadlová aminokyselina dokáže vyhladovět rakovinné buňky a přitom nepoškodí zdravé, ukázala studie","url":"https://techtools.cz/tools/news/clanek/807-zrcadlova-aminokyselina-dokaze-vyhladovet-rakovinne-bunky-a-pritom-neposkodi","api_url":"https://techtools.cz/news-api/v1/articles/807?lang=cs"},"content":"An international team led by the Universities of Geneva and Marburg has discovered that D-cysteine — a mirror-image version of the naturally occurring amino acid cysteine — can dramatically slow cancer growth while sparing healthy cells. The molecule enters cancer cells through a specific transporter found only on certain tumor surfaces and blocks the NFS1 enzyme in mitochondria, cutting off iron-sulfur cluster production essential for cellular respiration and DNA synthesis.\n\nIn mice with aggressive mammary tumors, D-cysteine treatment significantly slowed tumor progression with minimal side effects. \"D-Cys is imported into cells via a specific transporter that is present only on certain cancer cells,\" said Joséphine Zangari, first author of the study. The findings, published in Nature Metabolism, open a potential new pathway for targeted cancer therapy, though human clinical trials are still needed to confirm safety and efficacy."}}